Riesgo de caídas y consumo de fármacos en los pacientes mayores de 65 años. Estudio PYCAF

Yedro, M. Turégano; Villén, A. Núñez; Vigara, J.C. Romero; Cinza‐Sanjurjo, Sergio; Velilla-Zancada, Sonsoles; Segura‐Fragoso, Antonio; Expósito, J.M. Ignacio; Rivero, Javier Benítez; Rojas, M.B. Esteban; Llisterri, J.L.

doi:10.1016/j.semerg.2019.05.009

Cited by 7 publications

(3 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is a close association between polypharmacy and a significant increase in the risk of falls, especially if five or more drugs are being taken (Romano et al, 2017 ; Sattar et al, 2021 ). Psychotropic drugs (benzodiazepines, antipsychotics, antidepressants and sedative hypnotics) have been associated with a particularly high risk and a reduction in motor coordination (Turégano Yedro et al, 2019 ).…”

Section: Discussionmentioning

confidence: 99%

Accumulated incidence of falls in people hospitalised with cancer and related factors

et al. 2023

View full text Add to dashboard Cite

Aim To study the accumulated incidence of falls of people hospitalised with cancer and analyse the related intrinsic and extrinsic factors. Design A prospective study of people hospitalised with cancer at the Catalan Institute of Oncology. Methods Intrinsic factors and extrinsic factors related to the fall have been studied. The data were gathered from the clinical history and a specific adverse events notification programme and patients were followed during hospitalisation. Results A total of 117 of 6090 patients admitted during the period of study were included, with an accumulated incidence of falls of 0.019. Mean age 63.4 years (SD 11.5) and 65.5% men. Patients with lung cancer accounted for 25.6% of the total number of falls, followed by haematological cancer at 24.8%. Most falls were without consequences (71.8%). The data reveal that people hospitalised with cancer are at greater risk of falling, even though the accumulated incidence observed in the present study is low.

show abstract

Section: Discussionmentioning

confidence: 99%

Accumulated incidence of falls in people hospitalised with cancer and related factors

et al. 2023

View full text Add to dashboard Cite

show abstract

“…We can also observe this association between social factors and prevalence of dyslipidemia when we analyze the data in each country, with a higher prevalence among women, probably because of a higher prevalence of obesity, and among populations with low income and low educational level [4]. On the other hand, in developed countries, the prevalence of CVD increases with age, and it can, for example, increase the fragility of patients and worsen their prognosis [7][8][9].…”

Section: Introductionmentioning

confidence: 86%

Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

Pallarés-Carratalá

Barrios

Fierro-González³

et al. 2023

IJERPH

View full text Add to dashboard Cite

Objective: The aim of this study was to evaluate, through a survey, the opinion of primary care (PC) physicians on the magnitude of dyslipidemia and its degree of control in their clinical practice. Materials and methods: An ecological study was carried out, in which the physicians were invited to participate by means of an online letter. Data were collected at a single timepoint and were based only on the experience, knowledge, and routine clinical practice of the participating physician. Results: A total of 300 physicians answered the questionnaire and estimated the prevalence of dyslipidemia between 2% and 80%. They estimated that 23.5% of their patients were high-risk, 18.2% were very high-risk, and 14.4% had recurrent events in the last 2 years. The PC physicians considered that 61.5% of their patients achieved the targets set. The participants fixed the presence of side-effects to statins at 14%. The statin that was considered safest with regard to side-effects was rosuvastatin (69%). Conclusions: PC physicians in Spain perceive that the CVR of their patients is high. This, together with the overestimation of the degree of control of LDL-C, could justify the inertia in the treatment of lipids. Moreover, they perceive that one-sixth of the patients treated with statins have side-effects.

show abstract

“…Todos los medicamentos tienen potencial riesgo de causar algún evento adverso, sin embargo, se pone énfasis en los medicamentos de alto riesgo porque son aquellos que por sus características propias, tienen un margen terapéutico estrecho que pueden causar daño, e incluso la muerte cuando se producen errores en su administración. Esta definición no indica que los errores asociados a estos medicamentos sean más frecuentes, sino que, en caso de producirse las consecuencias para los pacientes suelen ser más graves (11).…”

Section: Artículo De Revisiónunclassified

Medicación de alto riesgo en personas adultas

Chiriguaya Savinovich

2023

Más Vita. Rev. Cienc. Salud

View full text Add to dashboard Cite

Introducción: La medicación de alto riesgo en personas adultas se refiere a aquellos medicamentos que pueden causar efectos adversos graves o incluso poner en peligro la vida del paciente; estos medicamentos requieren una atención especial en su prescripción, administración y seguimiento para minimizar los riesgos-garantizar la seguridad del paciente. Objetivo: Determinar pautas que posibiliten una adecuada medicación de alto riesgo en personas adultas en Ecuador. Materiales y métodos: cualitativa, descriptiva, revisión bibliográfica e infográfica de los últimos cinco años. Resultados: la mayoría son mujeres en un 76,8%, siendo la edad promedio de 64,3 años. Los medicamentos de alto riesgo más usado fueron los anestésicos, opiáceos, antiarrítmicos, Agonistas adrenérgicos, trombolíticos. Además, los errores consecutivos, estuvo la dosis, concentración, volúmenes y presentación. Conclusiones: El riesgo aumenta a partir de la edad superior a los 60 y ser mujer duplica el peligro, junto a la interacción fármaco-edad y la poli farmacología recurrente durante el período de vida, ya que, el triángulo de riesgo sobre fármacos es preocupante para una incidencia mayor a daños. Por eso, es importante la concepción de los protocolos y manejo de los fármacos de alto riesgo sobre la base de los errores más frecuentes

show abstract

Riesgo de caídas y consumo de fármacos en los pacientes mayores de 65 años. Estudio PYCAF

Cited by 7 publications

References 26 publications

Accumulated incidence of falls in people hospitalised with cancer and related factors

Accumulated incidence of falls in people hospitalised with cancer and related factors

Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

Medicación de alto riesgo en personas adultas

Contact Info

Product

Resources

About